AlphaStocks
7.0
Consider Buy

Davita Inc. (DVA)

As of Sep 20, 2026, Davita Inc. (DVA) scores 7.0/10 on AlphaStocks' five-model composite, #14 of 168 Health Care stocks. At $184, DVA trades 29% below its model fair value of $261.

Health Care / Health Care Services

S&P 500

$183.88

Above average across most dimensions. A solid candidate.

Consider Buy

Score based on 5 of 5 models — high confidence

Data as of Sep 20, 2026

#14out of 168 in Health Care

Is DAVITA INC. a Good Investment in 2026?

DAVITA INC. (DVA) scores 7.0 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates DAVITA INC. as Attractive (6/9). The Lynch model is the least favorable, rating it Neutral. DAVITA INC. currently trades 29% below its estimated fair value of $261. DAVITA INC. ranks #14 out of 168 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E12.9ROE-176.4Market Cap13B

Estimated Fair Value

$260.6229% below

Trading below estimated fair value. P/E of 13x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

Price vs intrinsic value

Lynch

Neutral

PEG 1.9 · Stalwart

Greenblatt

Attractive

Earnings yield 8.0% · ROC 58%

Frequently Asked Questions

Is DAVITA INC. (DVA) a good investment?
As of Sep 20, 2026, Davita Inc. (DVA) scores 7.0/10 on AlphaStocks' five-model composite, #14 of 168 Health Care stocks. At $184, DVA trades 29% below its model fair value of $261. That score is above average across most investment dimensions.
What is DAVITA INC.'s Piotroski F-Score?
DAVITA INC.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is DVA overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $261, DVA appears undervalued. The stock currently trades 29% below its estimated fair value. Trading below estimated fair value. P/E of 13x is moderate for this quality level.
How does DVA compare to other Health Care stocks?
DAVITA INC. ranks #14 out of 168 stocks in the Health Care sector, placing it in the top 8% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about DVA?
AlphaStocks evaluates DVA using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 7.0/10.

Similar Stocks

MDDGXLH

Compare DVA with

DVA vs MDDGX vs DVADVA vs LH

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer